Entos Revenue and Competitors
Estimated Revenue & Valuation
- Entos's estimated annual revenue is currently $7.8M per year.
- Entos's estimated revenue per employee is $126,150
- Entos's total funding is $53M.
Employee Data
- Entos has 62 Employees.
- Entos grew their employee count by 0% last year.
Entos's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder and CEO | Reveal Email/Phone |
2 | Cofounder and CTO | Reveal Email/Phone |
3 | VP Analytical Technologies | Reveal Email/Phone |
4 | VP, Head Chemistry | Reveal Email/Phone |
5 | SVP, Business Development | Reveal Email/Phone |
6 | VP, Biology | Reveal Email/Phone |
7 | VP, Finance | Reveal Email/Phone |
8 | Director, Biology | Reveal Email/Phone |
9 | Chief Scientific Officer | Reveal Email/Phone |
10 | Director, Finance And Operations | Reveal Email/Phone |
Entos Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.9M | 29 | 4% | N/A | N/A |
#2 | $43.4M | 272 | 8% | N/A | N/A |
#3 | $14.1M | 97 | 11% | N/A | N/A |
#4 | $1460M | 8291 | 7% | $1.1B | N/A |
#5 | $310M | 1527 | 20% | N/A | N/A |
#6 | $194.1M | 956 | -5% | N/A | N/A |
#7 | $223.9M | 1080 | -33% | $101.6M | N/A |
#8 | $581.3M | 2708 | 9% | $253.1M | N/A |
#9 | $716.2M | 3528 | 2% | N/A | N/A |
#10 | $801.4M | 3948 | 52% | N/A | N/A |
What Is Entos?
Entos drives chemical and biological innovation through thousand-fold speed ups in molecular prediction with transformative improvements in accuracy. Contact us to learn more about our software and machine-learning solutions.
keywords:N/A$53M
Total Funding
62
Number of Employees
$7.8M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Entos News
Dr John Lewis, CEO of Entos Pharmaceuticals, outlines how an innovative proteolipid platform could enable a new class of DNA-based vaccines...
Steve Chen brings over 20 years of academic research and pharmaceutical biotechnology experience across multiple therapeutic areas to Entos. He...
Entos, Inc (“Entos” or “the Company”), the creator of a cutting-edge platform combining AI-driven technology and automated synthetic development to design small-molecule therapeutics, today announced the closing of a $53 million Series A financing round led by Coatue, a leading technology invest ...
Entos, Inc., a San Diego, CA-based creator of a platform combining AI-driven technology and automated synthetic development to design small-molecule therapeutics, closed a $53m Series A financing. The round was led by Coatue and Catalio Capital Management, with participation from OrbiMed and Se ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $12.3M | 62 | -22% | $39.1M |
#2 | $8.4M | 62 | 9% | N/A |
#3 | $11.4M | 62 | 7% | N/A |
#4 | $8.9M | 62 | -7% | N/A |
#5 | $15.1M | 62 | 7% | N/A |